Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity.
2011
Competing Interests: All authors are employees and shareholders of Baxter BioScience, a manufacturer of biologicals including influenza vaccines. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.
Funding: This study was funded by Baxter BioScience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
49
Citations
NaN
KQI